Circulating MicroRNAs as Potential Risk Biomarkers for Hematoma Enlargement after Intracerebral Hemorrhage

CNS Neuroscience and Therapeutics

Volumn 18, Issue 12, 2012, Pages 1003-1011

  Zheng, Hong Wei ^a   Wang, Yi Long ^a   Lin, Jin Xi ^a   Li, Na ^a   Zhao, Xing Quan ^a   Liu, Gai Fen ^a   Liu, Li Ping ^a   Jiao, Yan ^b   Gu, Wei Kuan ^b   Wang, David Z ^c   Wang, Yong Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Biomarker; Hematoma enlargement; Intracerebral hemorrhage; MicroRNA

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; MICRORNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENOMICS; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR PROBE; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SPECTROPHOTOMETER; SUPPORT VECTOR MACHINE; SYMPTOM;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; COMPUTATIONAL BIOLOGY; FEMALE; HEMATOMA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETROSPECTIVE STUDIES; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84870451897     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12019     Document Type: Article

References (32)

1. Lim JK, Hwang HS, Cho BM, et al. Multivariate analysis of risk factors of hematoma expansion in spontaneous intracerebral hemorrhage. Surg Neurol 2008;69:40-45, discussion 5.
2. Tan JR, Koo YX, Kaur P, et al. microRNAs in stroke pathogenesis. Curr Mol Med 2011;11:76-92.
3. Kumar S, Badrinath HR. Early recombinant factor VIIa therapy in acute intracerebral hemorrhage: promising approach. Neurol India 2006;54:24-27.
4. Harper G, Castleden CM, Potter JF. Factors affecting changes in blood pressure after acute stroke. Stroke 1994;25:1726-1729.
5. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993;24:987-993.
6. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006;94:776-780.
7. Tan KS, Armugam A, Sepramaniam S, et al. Expression profile of MicroRNAs in young stroke patients. PLoS ONE 2009;4:e7689.
8. Markham DW, Hill JA. MicroRNAs and heart failure diagnosis: MiR-acle or MiR-age? Circ Res 2010;106:1011-1013.
9. Di Stefano V, Zaccagnini G, Capogrossi MC, Martelli F. microRNAs as peripheral blood biomarkers of cardiovascular disease. Vascul Pharmacol 2011;55:111-118.
10. Li N, Wang Y, Wang W, et al. Contrast extravasation on computed tomography angiography predicts clinical outcome in primary intracerebral hemorrhage: a prospective study of 139 cases. Stroke 2011;42:3441-3446.
11. Saeed AI, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003;34:374-378.
12. Kirschner MB, Kao SC, Edelman JJ, et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS ONE 2011;6:e24145.
13. Liu DZ, Tian Y, Ander BP, et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 2010;30:92-101.
14. Rink C, Khanna S. MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics 2011;43:521-528.
15. Merk DR, Chin JT, Dake BA, et al. miR-29b participates in early aneurysm development in Marfan syndrome. Circ Res 2012;110:312-324.
16. Wang CM, Wang Y, Fan CG, et al. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Biochem Biophys Res Commun 2011;411:586-592.
17. Yang F, Zhang L, Wang F, et al. Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma. Neoplasia 2011;13:590-600.
18. Tatarano S, Chiyomaru T, Kawakami K, et al. Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines. Int J Oncol 2012;40:951-959.
19. Li J, Zhang Y, Zhao J, Kong F, Chen Y. Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells. Mol Cell Biochem 2011;357:31-38.
20. Madathil SK, Nelson PT, Saatman KE, Wilfred BR. MicroRNAs in CNS injury: potential roles and therapeutic implications. BioEssays 2011;33:21-26.
21. Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 2007;27:894-908.
22. Schaefer JS, Montufar-Solis D, Vigneswaran N, Klein JR. Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon. J Immunol 2011;187:5834-5841.
23. Matsushima K, Isomoto H, Inoue N, et al. MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer 2011;128:361-370.
24. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE 2011;6:e23937.
25. Koga M, Toyoda K, Naganuma M, et al. Nationwide survey of antihypertensive treatment for acute intracerebral hemorrhage in Japan. Hypertens Res 2009;32:759-764.
26. Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 2004;35:1364-1367.
27. Sang YH, Su HX, Wu WT, So KF, Cheung RT. Elevated blood pressure aggravates intracerebral hemorrhage-induced brain injury. J Neurotrauma 2011;28:2523-2534.
28. Rajajee V, Brown DM, Tuhrim S. Coagulation abnormalities following primary intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2004;13:47-51.
29. Teruel R, Perez-Sanchez C, Corral J, et al. Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome. J Thromb Haemost 2011;9:1985-1992.
30. Carhuapoma JR, Mayer SA, Hanley DF. Animal models and experimental treatments of intracerebral hemorrhage. Intracerebral Hemorrhage 2010;17:192-205.
31. Ziai WC, Torbey MT, Kickler TS, Oh S, Bhardwaj A, Wityk RJ. Platelet count and function in spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2003;12:201-206.
32. Schroen B, Heymans S. MicroRNAs and beyond: the heart reveals its treasures. Hypertension 2009;54:1189-1194.